Hallucinations (young adult, older person): look for an organic cause
BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.
Young adult: first psychotic episode
Fasting laboratory tests
- FBC
- CRP
- Serum electrolytes
- Serum calcium
- Serum creatinine with eGFR
- AST
- ALT
- GGT
- Fasting plasma glucose
- TSH
- Syphilis serology
- HIV serology (with the patient's consent)
- Hepatitis C serology (if risk factor)if neededRisk factor for HCV exposure: the C'JAAD booklet proposes it only in this case [2].
- Hepatitis B serology (if risk factor)if needednon-French guidelineRisk factor for HBV exposure: the Australian and New Zealand recommendation places hepatitis screening in the initial tests [3] and the German S3 recommendation among the tests guided by warning signs [4]. The French C'JAAD booklet cites only HCV serology [2].
- Vitamin B12if neededProposed routinely by the C'JAAD booklet (summary of the Australian recommendations) [2], but absent from the initial tests retained by the Dissaux review [5].
- Folateif neededProposed routinely by the C'JAAD booklet (summary of the Australian recommendations) [2], but absent from the initial tests retained by the Dissaux review [5].
- Antinuclear antibodies (ANA)if neededLooking for lupus or an autoimmune disease: proposed in the initial tests by the C'JAAD booklet and by the Dissaux review [2,5], to be discussed with the psychiatrist conducting the work-up.
- Serum copper and caeruloplasmin (Wilson disease)if neededLooking for Wilson's disease: proposed in the initial tests by the C'JAAD booklet (copper and caeruloplasmin) and by the Dissaux review (caeruloplasmin) [2,5].
- β-hCG (woman of childbearing potential)if neededWoman of childbearing potential, before any treatment: the C'JAAD booklet places it in the routine tests [2].
- CK (if catatonia, rigidity or fever)if needednon-French guidelineThe German S3 recommendation lists it among the optional tests, in the presence of signs pointing to a somatic cause, and counts a CK at least 4 times normal among the criteria for neuroleptic malignant syndrome [4]. The French C'JAAD booklet does not cite it [2].
Urine tests
- Urine drug screen (cannabis, cocaine, amphetamines, opiates)
Also consider
Do not order
Older person: recent hallucinations
Laboratory tests (non-fasting)
- FBC
- CRP
- Serum electrolytes
- Serum creatinine with eGFR
- Serum calcium
- Total serum protein
- Plasma glucose
- TSH (depending on the context)if needednon-French guidelineTargeted test according to the history and examination, as part of the work-up for confusion or cognitive disorders [9].
- Vitamin B12 (depending on the context)if needednon-French guidelineTargeted test according to the history and examination, as part of the work-up for confusion or cognitive disorders [9].
- Folate (if malnutrition or macrocytosis)if needednon-French guidelineThe Scottish SIGN 157 recommendation proposes vitamin B12 and folate if nutritional status is in doubt or in case of macrocytosis [10]. The initial tests of the HAS (2009) do not mention them [11].
- ASTif needednon-French guidelineThe Scottish SIGN 157 recommendation counts liver function tests among the usual tests for confusion, and an American Family Physician review among those to consider when the diagnosis is unclear [10,12]. The initial tests of the HAS (2009) do not mention them [11].
- ALTif needednon-French guidelineThe Scottish SIGN 157 recommendation counts liver function tests among the usual tests for confusion, and an American Family Physician review among those to consider when the diagnosis is unclear [10,12]. The initial tests of the HAS (2009) do not mention them [11].
- GGTif needednon-French guidelineThe Scottish SIGN 157 recommendation counts liver function tests among the usual tests for confusion, and an American Family Physician review among those to consider when the diagnosis is unclear [10,12]. The initial tests of the HAS (2009) do not mention them [11].
Also consider
Atypical psychosis in an adolescent or young adult: treatable inherited metabolic diseases
- In addition to the tests of the "Adulte jeune : premier épisode psychotique" tab, only for atypical features (see the note), choosing the lines according to the clinical context.
- Acute or fluctuating picture (confusion, headache, vomiting, after a protein-rich meal, surgery, valproate or corticosteroids): refer to the emergency department, where serum ammonia is measured urgently.
Laboratory tests
- Caeruloplasmin and serum copper (Wilson disease)if neededTremor, dystonia, dysarthria, liver involvement, or personality and behaviour disorders in adolescents: Wilson's disease presents with psychiatric disorders in 10% of patients [16]. Caeruloplasmin is low in 93% of patients (threshold 0.14 g/L), but a normal value does not rule out the diagnosis [16].
- 24-hour urinary copper (container supplied by the laboratory)if neededSuspected Wilson's disease: 24-hour urinary copper is part of the copper studies; complete collection, in a plastic or acid-washed glass container to avoid contamination [16].
- Total plasma homocysteine (not reimbursed in France)if neededRapid cognitive decline, peripheral neurological involvement, thrombosis, high myopia or ectopia lentis, marfanoid habitus: homocystinuria or remethylation disorder [17,18]. Total homocysteine is the first-line test; it is generally above 100 µmol/L in cystathionine β-synthase deficiency, but can be lower [19].
- Porphobilinogen, delta-aminolaevulinic acid, porphyrins and creatinine on a spot urine sample, collected during the attack (PBG and ALA not reimbursed in France)if neededPsychiatric disorders with unexplained abdominal pain, especially cyclical, dark or red urine, constipation, confusion: acute porphyria [17,18], to be considered especially in women aged 15 to 50 [20]. A urine sample during the attack is enough; 24-hour collection is not recommended [20].
Do not order
- Routine metabolic screening for any psychosis: not feasible, as these tests are neither sensitive nor specific in psychiatric patients (psychotropic drugs, sedentary lifestyle, diet, toxic substances) [17].
- Ammonia sampled in the community without immediate transport: falsely raised values from tourniquet or poor sample handling, unsuitable capillary sampling; the assay is done as an emergency [21].
- 24-hour urine collection for porphobilinogen: not recommended, a single sample during the attack is enough [20].
Sources (23)
- O'Brien J, Taylor JP, Ballard C, et al. Visual hallucinations in neurological and ophthalmological disease: pathophysiology and management. J Neurol Neurosurg Psychiatry. 2020;91(5):512-9.
- Krebs MO, Lejuste F. Psychoses débutantes : pour une prise en charge précoce et intégrée. Livret du Centre d'évaluation jeunes adultes-adolescents (C'JAAD), centre hospitalier Sainte-Anne, 2017 (synthèse des Australian Clinical Guidelines for Early Psychosis, 2e édition, 2016 ; édité avec le soutien d'un laboratoire pharmaceutique).
- Galletly C, Castle D, Dark F, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. Aust N Z J Psychiatry. 2016;50(5):410-472.
- Deutsche Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde (DGPPN). S3-Leitlinie Schizophrenie (living), Langfassung, AWMF-Registernummer 038-009, version MAGICapp du 17/10/2025 (fichier de décembre 2025).
- Dissaux N, Neyme P, Kim-Dufor DH, et al. Psychosis caused by a somatic condition: how to make the diagnosis? A systematic literature review. Children (Basel). 2023;10(9):1439.
- National Institute for Health and Care Excellence. Psychosis and schizophrenia in adults: prevention and management. Clinical guideline CG178, février 2014, dernière mise à jour le 4 septembre 2026.
- Assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : chapitre 14 (médicaments, toxiques), actes 1659 et 0659.
- American Psychiatric Association. The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition. Washington, DC : APA, 2020 (tableau 2, repris dans le diaporama de formation officiel de l'APA).
- Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet. 2014;383(9920):911-22.
- Scottish Intercollegiate Guidelines Network. SIGN 157: Risk reduction and management of delirium. Mars 2019.
- Haute Autorité de santé. Confusion aiguë chez la personne âgée : prise en charge initiale de l'agitation. Recommandations de bonne pratique, mai 2009.
- Veauthier B, Hornecker JR, Thrasher T. Recent-Onset Altered Mental Status: Evaluation and Management. Am Fam Physician. 2021;104(5):461-470.
- Badcock JC, Larøi F, Kamp K, et al. Hallucinations in older adults: a practical review. Schizophr Bull. 2020;46(6):1382-95.
- National Institute for Health and Care Excellence. Delirium: prevention, diagnosis and management in hospital and long-term care. Clinical guideline CG103, 28 juillet 2010, dernière mise à jour le 18 janvier 2023.
- National Institute for Health and Care Excellence. Dementia: assessment, management and support for people living with dementia and their carers. NICE guideline NG97, 20 juin 2018.
- Centre de référence de la maladie de Wilson et autres maladies rares liées au cuivre. Protocole national de diagnostic et de soins (PNDS) : maladie de Wilson, 8 novembre 2021, et synthèse à destination du médecin traitant (Haute Autorité de santé, novembre 2021).
- Demily C, Sedel F. Psychiatric manifestations of treatable hereditary metabolic disorders in adults. Ann Gen Psychiatry 2014;13:27.
- Bonnot O, Klünemann HH, Sedel F, Tordjman S, Cohen D, Walterfang M. Diagnostic and treatment implications of psychosis secondary to treatable metabolic disorders in adults: a systematic review. Orphanet J Rare Dis 2014;9:65.
- Morris AA, Kožich V, Santra S, Andria G, Ben-Omran TI, Chakrapani AB, et al. Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency. J Inherit Metab Dis 2017;40(1):49-74.
- Wang B, Bonkovsky HL, Lim JK, Balwani M. AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review. Gastroenterology 2023;164(3):484-491.
- Häberle J, Boddaert N, Burlina A, Chakrapani A, Dixon M, Huemer M, et al. Suggested guidelines for the diagnosis and management of urea cycle disorders. Orphanet J Rare Dis 2012;7:32.
- Geberhiwot T, Moro A, Dardis A, Ramaswami U, Sirrs S, Marfa MP, et al. Consensus clinical management guidelines for Niemann-Pick disease type C. Orphanet J Rare Dis 2018;13(1):50.
- Assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : actes 0547 (cuprémie), 1809 (céruloplasmine), 2008 (cuivre urinaire), 0637-0638 (porphyrines urinaires).